Further evidence for prolongation of survival of pancreatic cancer patients by efficacy orientated sequential polychemotherapy (EOSPC) based on serial tumor marker determinations (CA 19-9/CEA)

Anticancer Research

Volumn 25, Issue 3 A, 2005, Pages 1687-1691

  Klapdor, R ^a   Bahlo, M ^a   Babinsky, A ^a  

^a ZeTDT GmbH   (Germany)

Author keywords

CA19 9; CEA; Pancreatic cancer; Polychemotherapy

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; TUMOR MARKER;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PANCREAS CANCER; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 21244492334     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Ardalan B, Tian E et al: A phase II study of weekly 24-hour infusion with high dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 9: 625-630, 1991.
2. Klapdor R (für die Arbeitsgruppe): Arbeitsgruppe Qualitätskontrolle und Standardisierung von Tumormarkertests im Rahmen der Hamburger Symspoien über Tumormarker. Tumordiagn Ther 13: XIX-XXII, 1992.
3. Klapdor R, Seutter E, Lang-Pölkow EM, REichle H and Hinrichs A: Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination for mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers. Anticancer Res 19: 2459-2469, 1999.
4. EGTM-Conscensus Recommendations. Anticancer Res 19: 2785-2820, 1999.
5. Klapdor R, Martini-Svendsen J, Seutter R and Fenner C: Combination therapy with oxaliplatin + gemcitabine in advanced pancreatic cancer. Abstract 576, ECCO 10 Proceedings, 1999.
6. Klapdor R, Müller Chr, Seutter R, Bahlo M, Peters W and Fenner C: Improvement of survival by efficacy orientated sequential polychemotherapy of exocrine pancreatic cancer. Anticancer Res 20: 5201-5208, 2000.
7. Klapdor R, Mahlo M, Babinski A, Broemel T, Müller C and Seutter R: Sequential polychemotherapy in exocrine pancreatic cancer. Anticancer Res 23: 841-844, 2003.